The Role of Polymorphic Variants of Gene Components of the PTEN/PI3K/AKT Signaling Pathway in the Development of Prostate Cancer

被引:0
|
作者
Gilyazova, I. R. [1 ]
Ivanova, E. A. [1 ]
Bermisheva, M. A. [1 ]
Loginova, M., V [2 ]
Asadullina, D. D. [1 ]
Ishemgulov, R. R. [2 ]
Mustafin, A. T. [2 ]
Pavlov, V. N. [2 ]
Khusnutdinova, E. K. [1 ,2 ]
机构
[1] Russian Acad Sci, Inst Biochem & Genet, Ufa 450054, Russia
[2] Bashkir State Med Univ, Ufa 450008, Russia
关键词
prostate cancer; polymorphic variants of genes; PTEN; PI3K; AKT pathway; PTEN; MTOR; RISK; PI3K; P53;
D O I
10.1134/S1022795422070055
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The aim of this study was to search for associations of genotypes and alleles of polymorphic loci of the PTEN/PI3K/AKT pathway genes rs2494750 of AKT1, rs2735343, rs2299941, rs10490920 of PTEN, rs17878362 of TP53, and rs2699887 of PIK3CA with the risk of prostate cancer development. As a result of comparison allele and genotype frequencies between the general sample of prostate cancer patients and the control group of healthy individuals, it was found that the CG genotype of the polymorphic locus rs2735343 of PTEN is associated with an increased risk of developing the disease (OR = 1.38, 95%CI = 1.02-1.87, p = 0.04), whereas the GG genotype showed a decrease in the frequency of occurrence in the group of patients compared with the control (OR = 0.74, 95%CI = 0.55-0.99, p = 0.05). When stratifying the group of patients with prostate cancer, depending on histopathological characteristics, it was revealed that the rs2735343*C allele is associated with an increased risk of bilateral lesions of both prostate lobes and invasion of seminal vesicles. With allowance for further validating studies, the results of this work can be used to create a panel of molecular markers for disease prognosis and assessment of tumor characteristics.
引用
收藏
页码:844 / 849
页数:6
相关论文
共 50 条
  • [1] The Role of Polymorphic Variants of Gene Components of the PTEN/PI3K/AKT Signaling Pathway in the Development of Prostate Cancer
    I. R. Gilyazova
    E. A. Ivanova
    M. A. Bermisheva
    M. V. Loginova
    D. D. Asadullina
    R. R. Ishemgulov
    A. T. Mustafin
    V. N. Pavlov
    E. K. Khusnutdinova
    Russian Journal of Genetics, 2022, 58 : 844 - 849
  • [2] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
  • [3] The Role of Polymorphisms in Genes of PI3K/Akt Signaling Pathway on Prostate
    Xu, Wei
    Ni, Zhihao
    Zhang, Meng
    Chen, Jinbo
    Zhang, Li
    Wu, Song
    Liang, Chaozhao
    JOURNAL OF CANCER, 2019, 10 (04): : 1023 - 1031
  • [4] Role of the PI3K/AKT pathway and PTEN in otitis media
    Lee, Hwan Ho
    Chin, Anthony
    Pak, Kwang
    Wasserman, Stephen, I
    Kurabi, Arwa
    Ryan, Allen F.
    EXPERIMENTAL CELL RESEARCH, 2020, 387 (01)
  • [5] Interplay Among PI3K/AKT, PTEN/FOXO and AR Signaling in Prostate Cancer
    Yan, Yuqian
    Huang, Haojie
    PROSTATE CANCER: CELLULAR AND GENETIC MECHANISMS OF DISEASE DEVELOPMENT AND PROGRESSION, 2ND EDITION, 2019, 1210 : 319 - 331
  • [6] PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis
    Fang, Jing
    Ding, Min
    Yang, Lily
    Liu, Ling-Zhi
    Jiang, Bing-Hua
    CELLULAR SIGNALLING, 2007, 19 (12) : 2487 - 2497
  • [7] MicroRNAs and the PTEN/PI3K/Akt pathway in gastric cancer
    Hu, Mingli
    Zhu, Shixuan
    Xiong, Shengwei
    Xue, Xingxing
    Zhou, Xiaodong
    ONCOLOGY REPORTS, 2019, 41 (03) : 1439 - 1454
  • [8] The PI3K/AKT pathway in the pathogenesis of prostate cancer
    Chen, Huixing
    Zhou, Lan
    Wu, Xiaorong
    Li, Rongbing
    Wen, Jiling
    Sha, Jianjun
    Wen, Xiaofei
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2016, 21 : 1084 - 1091
  • [9] The role of the PTEN/PI3K/AKT-survival pathway for radiosensitization
    Zingg, D
    Tenzer, A
    Hofstetter, B
    Glanzmann, C
    Bodis, S
    Pruschy, M
    STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 : 114 - 114
  • [10] The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications
    Carnero, Amancio
    Blanco-Aparicio, Carmen
    Renner, Oliver
    Link, Wolfgang
    Leal, Juan F. M.
    CURRENT CANCER DRUG TARGETS, 2008, 8 (03) : 187 - 198